Tranexamic acid has been used clinically for 30 years to treat melasma and hyperpigmentation but this amazing skin lightener is just now becoming popular as more people become aware of its amazing effectiveness. Our Better Complexions Ultra Whitening with Retinoid combines 10% Tranexamic acid to lighten unwanted dark spots with .1% Retin A to increase penetration while at the same time exfoliating and improving collagen production to firm your skin.
Melasma is a common skin discoloration that occurs above the lips, on the cheeks, foreheads, and chins of females between 20 and 50 years of age. Melasma is more common in people with darker skin tones especially among those of Latin, Asian, and Middle Eastern descents. It is thought to be brought on by over-exposure to sunlight and hormonal changes from pregnancy and birth control medications.
Tranexamic acid has been found to be the most effective compound for overall skin whitening and lightening dark spots and pigmentation. It circumvents the melanin affected area and reduces the hyperpigmentation activity from the edges to the middle. It works from the edges of the melanin affected area to the center until they go away. It effectively prevents darkening of the skin due to sun exposure and aging. TA also lightens the pigmentation of acne, scars, sun overexposure, and skin spots related to medications and hormonal changes.
We've also added .1% Retinoid – to enhance penetration, exfoliate and shed the darkened cells and improve collagen production to firm your skin on a molecular level. If you haven't tried our Retinoid cream yet we highly recommend it too.
Kondou have released their findings from a clinical study looking at the effects of a tranexamic acid (TA) emulsion applied to areas of the skin affected by melasma and freckles. The study involved 33 testees 25 with melasma and 8 with freckles, who used TA topically for five to eighteen weeks, after which their skin pigmentation was visually examined by a dermatologist.
Doctors found that the TA emulsion had improved the dark spots and freckles in 20 patients with melasma (80%) and 6 (75%) with freckles. No side effect was recognized and thus the use of TA topically was deemed safe. In regard to changes over the course of the clinical study, noticeable improvement was discovered within 8 weeks for discolored skin areas caused by melasma and 12 weeks for skin areas with freckles; therefore, improvement was considered to require at least two months of topical application. The study concluded the TA applied topically was a practical cosmeceutical that provided a lightening effect on melasma and freckles through suppression of melanin synthesis. It also prevented the recurrence of new dark spots and freckles.
- UPC: 608938417077